We recently published a list of 7 Best ASX Stocks To Invest In Right Now. In this article, we are going to take a look at ...

SEATTLE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering ...

Vir Biotechnology Inc (VIR) stock saw a decline, ending the day at $7.8 which represents a decrease of $-0.13 or -1.64% from the prior close of $7.93. The stock opened at $7.94 and touched a low of $7 ...

A Professor of Microbiology and Biotechnology at the Edo State University (EDSU), Uzairue, Charles Adetunji, has stressed the ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on PDS Biotechnology (PDSB – Research Report). The ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

Minister of Agriculture and Food Security, Senator Abubakar Kyari has underscored the important role of modern biotechnology ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the exclusive worldwide license agreement with Sanofi announced on ...

September/1992024/biotechnology-img.jpg" width="1200" height="675" /> CBSE Class 10 Biotechnology Sample paper 2025: The Central Board Of Secondary Education (CBSE) has made sample paper available for ...

The Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the continuation of two umbrella schemes from the ...

The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, today approved continuation of the two umbrella schemes ...